Training Dogs to Diagnose Parkinson’s
Image courtesy of padsforparkinsons.org Joy Milne was a nurse who lived much of her life oblivious to her hidden ability. But one day, she…
Image courtesy of padsforparkinsons.org Joy Milne was a nurse who lived much of her life oblivious to her hidden ability. But one day, she…
Analysts had high hopes for anti-amyloid drug Aduhelm — the first Alzheimer’s treatment approved by the FDA in nearly two decades and the first…
UPDATE: 3 March 2024, 8:25 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
UPDATE: 3 March 2024, 8:22 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
Beta-amyloid plaques are a hallmark of Alzheimer’s, but researchers have long been puzzled about why these plaques can also be found in the brains…
Since the early days of the novel coronavirus pandemic, researchers found that people living with Alzheimer’s were at a higher risk of severe COVID-19…
You may have read about it in the New York Post: “Scientists pinpoint personality traits that increase risk of Alzheimer’s.” A recent study published in…
Almost 60 percent of people with Alzheimer’s also show signs of seizure-like brain activity. In total, more than one fifth of people with Alzheimer’s…
Analyzing large databases of human data, scientists identified a “water pill” called bumetanide, which reduced the risk of developing Alzheimer’s for people with a…
Time is of the essence when it comes to Alzheimer’s — early diagnosis provides more time to intervene and slow its progress. Current technology…
Physicians are in a race against time to diagnose Alzheimer’s. While treatments and interventions can slow the clock, spotting the disease early is key…
The amyloid hypothesis—the idea that Alzheimer’s is caused by clumps of proteins known as beta-amyloid—remains unproven. But scientists are holding out hope that monoclonal…
In the future, implantable devices that interface with the brain could help people with severe neurodegenerative movement disorders communicate again through a computer or…
The biotechnology company Eisai Co., Ltd. announced a rolling submission for accelerated approval from the Food and Drug Administration for their anti-amyloid Alzheimer’s treatment,…
Early data presented by Cassava Sciences demonstrates the safety of their Alzheimer’s drug simufilam, which is currently in Phase 3 clinical trials. But in late…